Skip to content

Compare

Compounded vs brand-name GLP-1 medication

What is the difference between compounded and brand-name GLP-1 medication?

In short

A brand-name GLP-1 medicine (Wegovy, Ozempic, Zepbound, Mounjaro) is an FDA-approved product: the FDA has reviewed it for safety, effectiveness and manufacturing quality. A compounded GLP-1 preparation is made by a licensed pharmacy for an individual prescription and is not an FDA-approved product; it is not a generic, and the FDA does not review it before it is dispensed. Compounding exists for legitimate reasons and is legal within limits, but the quality you get depends entirely on the pharmacy, which is why Vivo publishes the standards it reviews pharmacy partners against.

Brand-name product compared with Compounded preparation
Brand-name productCompounded preparation
FDA approvalYes: reviewed for safety, effectiveness and manufacturing qualityNo: compounded drugs are not FDA-approved products and are not reviewed before dispensing
Who makes itThe manufacturer, under FDA inspectionA licensed 503A pharmacy (individual prescriptions) or 503B outsourcing facility (FDA-registered, cGMP)
Is it a generic?Not applicableNo. A generic is itself an FDA-approved product; a compounded drug is not
When it can be compoundedNot applicableWithin federal and state rules, for example during an FDA-declared shortage or when a patient needs a form or strength that is not commercially available
Quality oversightFDAState board of pharmacy (503A) or FDA registration and cGMP (503B); the pharmacy's own testing
Typical costHigher without insurance coverageUsually lower; varies by pharmacy and dose
What to askIs this the approved product in its original packaging?Which pharmacy, licensed where, 503A or 503B, what testing, what concentration, how to store it

What approval means and what it does not

FDA approval means a product's safety, effectiveness and manufacturing have been reviewed and are inspected. It does not mean the approved product is the only legitimate option, and it does not mean every compounded preparation is unsafe. It means the burden of proving quality shifts: with an approved product it sits with the manufacturer and the FDA; with a compounded preparation it sits with the pharmacy, the prescriber and you.

When compounding is allowed

Federal law lets licensed pharmacies compound a medication for an individual patient within limits, including when the FDA lists a drug as in shortage or when a patient needs a form or strength that is not commercially available. The FDA's shortage lists and its policy on compounded GLP-1 medicines have changed over time, so what a pharmacy may lawfully prepare today can differ from last year. A reputable clinic tells you which rule its pharmacy is working under; if nobody can answer that, keep asking.

503A and 503B, and why the difference matters

A 503A pharmacy compounds for individual prescriptions and is overseen mainly by its state board of pharmacy. A 503B outsourcing facility registers with the FDA, follows current good manufacturing practice and is inspected by the FDA. Vivo works with vetted U.S. pharmacy partners in both categories where applicable, and reviews them against seven standards: facility registration and inspection history, the regulatory basis for compounding each product, finished-lot identity and content testing, sterility and endotoxin reports, manufacturing controls, stability and storage support, and ingredient traceability.

How Vivo approaches it

The medicine is never the starting point. The evaluation is: labs, history and goals, then a licensed provider decides whether a GLP-1 medicine is appropriate at all. Where it is, the provider and the care team tell you exactly what is being prescribed, which pharmacy dispenses it, how it is tested and how to store and use it. Compounded medications are not FDA-approved products, and Vivo says so on every page that mentions them.

Getting started at Vivo is a $200 onboarding and initial consultation, or the $500 at-home lab package that includes it.

Sources

  1. FDA: Human drug compounding
  2. FDA: Medications containing semaglutide marketed for type 2 diabetes or weight loss
  3. FDA: Drug shortages database

Medically reviewed by: Vivo Clinical Team · Licensed medical providers · Last reviewed November 2026 · Educational information, not medical advice. Compounded medications are not FDA-approved products.

Next step

The comparison that matters is the one with your labs in it.

A licensed provider decides what fits you after your history and results are reviewed together.

Questions

Questions people ask next.

What comes up after compounded vs brand-name glp-1 medication.

  • No. There is no FDA-approved generic semaglutide. A compounded preparation is made by a pharmacy for an individual prescription and is not an FDA-approved product.

  • It depends on the pharmacy. The FDA has warned about dosing errors and about products sold outside licensed pharmacies. Ask which pharmacy, whether it is a 503A pharmacy or 503B outsourcing facility, what testing is done on each lot, and what concentration you are receiving.

  • It is prepared by a pharmacy rather than bought as the branded product, and its price is not set by the manufacturer. Lower cost says nothing on its own about quality in either direction.

  • Yes. Which pharmacy, licensed where, how it is tested and how to store it are part of every plan that includes a prescription.